Literature DB >> 15464634

Epilepsy surgery for tuberous sclerosis.

Pantaleo Romanelli1, Magda Verdecchia, Raul Rodas, Stefano Seri, Paolo Curatolo.   

Abstract

Tuberous sclerosis complex is often associated with medically refractory epilepsy secondary to cortical tubers. Previous studies have identified an association between early seizure onset, greater seizure burden, and mental retardation in childhood. Early effective seizure control could therefore significantly reduce the adverse developmental effects of chronic epilepsy in tuberous sclerosis complex. In medically intractable epileptic patients, surgical treatment has been demonstrated to reduce or abolish seizures and the associated burden for the child and its environment. Epilepsy surgery has not been widely used in patients with tuberous sclerosis complex thus far, mostly because of the concern that the multifocal nature of the cortical lesions could be associated with the development of independent epileptogenic zones. Advances in electroencephalographic techniques, functional neuroimaging, and invasive cortical mapping are changing this view and allowing an increased number of tuberous sclerosis complex patients to be evaluated for resective surgery. Additional techniques emerging in the neurosurgical field may add further treatment options to the current state of the art.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15464634     DOI: 10.1016/j.pediatrneurol.2004.05.012

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  9 in total

1.  Do we still need invasive recordings? If so for how much longer?

Authors:  William Harkness
Journal:  Childs Nerv Syst       Date:  2010-03-06       Impact factor: 1.475

2.  Unique findings of subependymal giant cell astrocytoma within cortical tubers in patients with tuberous sclerosis complex: a histopathological evaluation.

Authors:  Joel S Katz; Hyman Frankel; Tracy Ma; David Zagzag; Benjamin Liechty; Bruria Ben Zeev; Michal Tzadok; Orrin Devinsky; Howard L Weiner; Jonathan Roth
Journal:  Childs Nerv Syst       Date:  2017-01-10       Impact factor: 1.475

3.  Imaging findings of structural causes of epilepsy in children: a guide for the radiologist in the emergency room.

Authors:  James M Provenzale
Journal:  Emerg Radiol       Date:  2010-07-02

Review 4.  Tuberous sclerosis complex: a review of the management of epilepsy with emphasis on surgical aspects.

Authors:  Mary B Connolly; Glenda Hendson; Paul Steinbok
Journal:  Childs Nerv Syst       Date:  2006-06-13       Impact factor: 1.475

5.  Volumetric localization of epileptic activities in tuberous sclerosis using synthetic aperture magnetometry.

Authors:  Zheng Xiao; Jing Xiang; Stephanie Holowka; Amrita Hunjan; Rohit Sharma; Hiroshi Otsubo; Sylvester Chuang
Journal:  Pediatr Radiol       Date:  2005-10-21

Review 6.  Management of subependymal giant cell tumors in tuberous sclerosis complex: the neurosurgeon's perspective.

Authors:  Moncef Berhouma
Journal:  World J Pediatr       Date:  2010-05-21       Impact factor: 2.764

7.  Global and intertuberal epileptic networks in tuberous sclerosis based on stereoelectroencephalographic (sEEG) findings: a quantitative EEG analysis in pediatric subjects and surgical implications.

Authors:  H Alexander; R B Govindan; T Anwar; V C Chirumamilla; I Fayed; R F Keating; W D Gaillard; C O Oluigbo
Journal:  Childs Nerv Syst       Date:  2021-08-29       Impact factor: 1.475

8.  Current role of surgery for tuberous sclerosis complex-associated epilepsy.

Authors:  Nicola Specchio; Giusy Carfi Pavia; Luca de Palma; Alessandro De Benedictis; Chiara Pepi; Marta Conti; Carlo Efisio Marras; Federico Vigevano; Paolo Curatolo
Journal:  Pediatr Investig       Date:  2022-02-21

9.  Localization of the epileptogenic foci in tuberous sclerosis complex: a pediatric case report.

Authors:  Alexander Hunold; Jens Haueisen; Banu Ahtam; Chiran Doshi; Chellamani Harini; Susana Camposano; Simon K Warfield; Patricia Ellen Grant; Yoshio Okada; Christos Papadelis
Journal:  Front Hum Neurosci       Date:  2014-03-26       Impact factor: 3.169

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.